2013
Update on Portal Vein Embolization: Evidence-based Outcomes, Controversies, and Novel Strategies
May BJ, Talenfeld AD, Madoff DC. Update on Portal Vein Embolization: Evidence-based Outcomes, Controversies, and Novel Strategies. Journal Of Vascular And Interventional Radiology 2013, 24: 241-254. PMID: 23369559, DOI: 10.1016/j.jvir.2012.10.017.Peer-Reviewed Original ResearchMeSH KeywordsCarcinoma, HepatocellularEmbolization, TherapeuticEvidence-Based MedicineHepatic VeinsHumansLiver NeoplasmsTreatment OutcomeConceptsPortal vein embolizationFuture liver remnantVein embolizationCurative hepatic resectionPortal blood flowNumber of patientsTumor-bearing liverRecent outcome dataEvidence-based outcomesPostoperative morbidityFLR hypertrophyHepatic resectionLiver remnantPatient outcomesBlood flowOutcome dataNovel strategyEmbolizationSurgeryTherapyOutcomesMorbidityResectionPatientsHypertrophy
2011
Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation
Kneteman N, Livraghi T, Madoff D, de Santibañez E, Kew M. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation. Liver Transplantation 2011, 17: s117-s127. PMID: 21584926, DOI: 10.1002/lt.22334.Peer-Reviewed Original ResearchMeSH KeywordsBiomarkers, TumorCarcinoma, HepatocellularDecision Support TechniquesDiagnostic ImagingEvidence-Based MedicineHealth Status IndicatorsHumansLiver NeoplasmsLiver TransplantationNeoplasm Recurrence, LocalNeoplasm StagingPatient SelectionPractice Guidelines as TopicPredictive Value of TestsRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeWaiting Lists